advertisement
Tang J 21
Showing records 1 to 21 |
Display all abstracts from Tang J106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trialLi S
Eye and vision (London, England) 2022; 9: 44
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug CandidateWang J
ACS pharmacology & translational science 2022; 5: 752-760
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress ResponseTang J; Liu Z
Antioxidants (Basel, Switzerland) 2022; 11:
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trialGuo L
Eye and vision (London, England) 2022; 9: 44
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug CandidateLi B; Tang J
ACS pharmacology & translational science 2022; 5: 752-760
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trialZhou P
Eye and vision (London, England) 2022; 9: 44
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress ResponseHan J
Antioxidants (Basel, Switzerland) 2022; 11:
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug CandidateQiu L
ACS pharmacology & translational science 2022; 5: 752-760
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trialTang J
Eye and vision (London, England) 2022; 9: 44
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress ResponseXue J; Liu L
Antioxidants (Basel, Switzerland) 2022; 11:
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trialWang Z
Eye and vision (London, England) 2022; 9: 44
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug CandidateQiao X
ACS pharmacology & translational science 2022; 5: 752-760
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trialZhang L
Eye and vision (London, England) 2022; 9: 44
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress ResponseLin J
Antioxidants (Basel, Switzerland) 2022; 11:
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug CandidateXu N
ACS pharmacology & translational science 2022; 5: 752-760
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress ResponseWu C
Antioxidants (Basel, Switzerland) 2022; 11:
105779 Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug CandidateYang H
ACS pharmacology & translational science 2022; 5: 752-760
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trialZhao M
Eye and vision (London, England) 2022; 9: 44
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress ResponseZhang Q
Antioxidants (Basel, Switzerland) 2022; 11:
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trialQu J
Eye and vision (London, England) 2022; 9: 44
106154 Increased Mobile Zinc Regulates Retinal Ganglion Cell Survival via Activating Mitochondrial OMA1 and Integrated Stress ResponseWu S; Liu C; Huang H; Fu Y; Li M; Zhuo Y; Li Y
Antioxidants (Basel, Switzerland) 2022; 11:
Issue 23-3
Change Issue
advertisement